Ileal carbohydrates inhibit cholinergically stimulated exocrine pancreatic secretion in humans
Tóm tắt
Ileal inhibitory effects on pancreatic enzyme output are also demonstrable during exogenous, cholinergic stimulation of exocrine pancreatic secretion. These findings support the hypothesis that direct inhibition of cholinergic systems may be involved in the ileal inhibitory effects on pancreatic enzyme secretion. Furthermore, glucagon-like peptide-1 (GLP-1) may play a role in the mediation of the ileum-induced effects. Ileal carbohydrate perfusion inhibits endogenously stimulated exocrine pancreatic secretion in humans. Our aim was to investigate if ileal perfusion of carbohydrates exerts similar effects on exogenously stimulated pancreatic enzyme output, i.e., if the inhibitory mechanisms are reproducible during direct, cholinergic stimulation of the exocrine pancreas. Furthermore, we sought to clarify the role of the potential humoral mediators (GLP-1) and peptide YY (PYY). Eight healthy fasting volunteers were intubated with an oroileal multilumen tube system for aspiration of duodenal juice and perfusion of test solutions. Exocrine pancreatic secretion was stimulated by a continuous iv infusion of the cholinergic agonist carbachol. Additionally, the ileum was perfused for 15-min intervals with either carbohydrates (total load: 18 g) or saline as control. Blood samples for determination of GLP-1 and PYY were taken before the beginning of exogenous stimulation and before and after ileal perfusion. Exogenously stimulated pancreatic enzyme secretion was significantly inhibited by additional ileal carbohydrate perfusion (p<0.05), whereas ileal saline had no effect. Moreover, plasma levels of GLP-1 increased significantly (p=0.004) after ileal perfusion of carbohydrates, but not after saline. PYY plasma concentrations remained unchanged after both ileal perfusates.
Tài liệu tham khảo
Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ, Silk DBA. The ileal brake-inhibition of jejunal motility after ileal fat perfusion in man.Gut 1984; 25: 365–374.
Spiller RC, Trotman IF, Adrian TE, Bloom SR, Misiewicz JJ, Silk DBA. Further characterisation of the “ileal brake” reflex in man—effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY.Gut 1988; 29: 1042–1051.
Read NW, McFarlane A, Kinsman RJ, Bates TE, Blackhall NW, Farrar GBJ, Hall JC, Moss G, Morris G, Morris AP, O'Neill B, Welch I, Lee Y, Bloom SR. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon.Gastroenterology 1984; 86: 274–280.
Layer P, Zinsmeister AR, DiMagno EP. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans.Gastroenterology 1986; 91: 41–48.
Clain JE, Go VLW, Malagelada JR. Inhibitory role of the distal small intestine on the gastric secretory response to meals in man.Gastroenterology 1978; 74: 704–707.
Layer P, Peschel S, Schlesinger T, Goebell H. Human pancreatic secretion and intestinal motility: effects of ileal nutrient perfusion.Am J Physiol 1990; 258 (Gastrointest Liver Physiol 21): G196-G201.
Anderson IH, Levine AS, Levitt MD. Incomplete absorption of the carbohydrate in all-purpose wheat flour.N Engl J Med 1981; 304: 891, 892.
Levitt MD. Malabsorption of starch: a normal phenomenon.Gastroenterology 1983; 85: 769, 770.
Stephen AM, Haddad AC, Phillips SF. Passage of carbohydrate into the colon.Gastroenterology 1983; 85: 589–595.
Kreyman B, Ghatei MA, Williams G, Bloom SR. Glucagon-like peptide-1 (7–36): a physiological incretin in man.Lancet 1987; II: 1300–1304.
O'Halloran DJ, Nikou GC, Kreyman B, Ghatei MA, Bloom SR. Glucagon-like peptide-1 (6–36)-NH2: a physiological inhibitor of the gastric acid secretion in man.J Endocrinol 1990; 126: 169–173.
Schjoldager BTG, Mortensen PE, Christiansen J, Orskov C, Holst JJ. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans.Dig Dis Sci 1989; 34: 703–708.
Wettergren A, Schjoldager B, Mortensen PE, Petersen H, Orskov C, Holst JJ. Effect of GLP-1 on gastric motility and gastric and pancreatic secretion in man.Digestion 1993; 54: 384, 385.
Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR. Human distribution and release of a putative new gut hormone, peptide YY.Gastroenterology 1985; 89: 1070–1077.
Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, Bloom SR. Effect of peptide YY on gastric, pancreatic, and biliary function in humans.Gastroenterology 1985; 89: 494–499.
Allen JM, Fitzpatrick ML, Yeats JC, Darcy K, Adrian TE, Bloom SR. Effect of peptide YY and neuropeptide Y on gastric emptying in man.Digestion 1984; 30: 255–262.
Layer P, Grandt D, Rippel K, Schimiczek M, Kölbel C, Beglinger C, Reeve JR, Eysselein VE, Goebell H. Ist Peptid YY (PYY) ein hormonaler Regulator der Pankreas- und Gallesekretion und intestinalen Motilität des Menschen?Z Gastroenterol 1992; 30: 651.
Bernfeld P. Alpha-amylases, in: Colowick CO, Kaplan NO, eds.Methods of Enzymology, Vol. I. Hrsg, New York 1955; pp. 149–158.
Hummel BC. A modified spectrophotometric determination of chymotrypsin, trypsin and thrombin.Can J Biochem 1955; 37: 1393–1397.
Ziegenhorn J, Neumann U, Knitsch KW, Zwenz W. Determination of serum lipase.Clin Chem 1979; 25: 1067.
Layer P, Chan ATH, Go VLW, DiMagno EP. Human pancreatic secretion during phase II antral motility of the interdigestive cycle.Am J Physiol 1988; 254 (Gastrointest Liver Physiol 17): G249-G253.
Go VLW, Hoffmann AF, Summerskill WHJ. Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique.Gastroenterology 1970; 58: 321–328.
Layer P, Go VLW, DiMagno DP. Fate of pancreatic enzymes during aboral small intestinal transit in humans.Am J Physiol 1986; 251 (Gastrointest Liver Physiol 14): G475-G480.
Wingate DL, Sandberg RJ, Phillips SF. A comparison of stable and14C-labelled polyethylene glycol as volume indicators in the human jejunum.Gut 1972; 13: 812–815.
Orskov C, Jeppesen J, Madsbad S, Holst JJ. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.J Clin Invest 1991; 87: 415–423.
Layer P, Holst JJ, Grandt D, Goebell H. Ileal release of glucagon-like peptide-1 (GLP-1): association with inhibition of gastric acid secretion in humans.Dig Dis Sci 1995; 40: 1074–1082.
Holst JJ, Bersani M. Assays for peptide products of somatostatine gene expression, inMethods in Neurosciences, vol. 5, Neuropeptide Technology, Conn MP, ed. Academic, San Diego, 1991, pp. 3–22.
Box GEP, Hunter WG, Hunter JS.Statistics for Experimenters. John Wiley & Sons, New York: 1978.
Jain NK, Boivin M, Zinsmeister AR, DiMagno EP. The ileum and carbohydrate mediated feedback regulation of postprandial pancreaticobiliary secretion in normal humans.Pancreas 1991; 6: 495–505.
Brown NJ, Read NW, Richardson A, Rumsey RDE, Bogentoft C. Characteristics of lipid substances activating the ileal brake in the rat.Gut 1990; 31: 1126–1129.
Layer P, Binczyk H, Leben J, Ohe M, Gröger G, Grandt D, Goebell H. Are adrenergic or opiate receptors involved in the mediation of ileum-induced alteration of exocrine pancreatic and intestinal motor function?Digestion 1991; 49: 33.
Hall KE, El-Sharkawy TY, Diamant NE. Vagal control of canine postprandial upper gastrointestinal motility.Am J Physiol 1986; 250 (Gastrointest Liver Physiol 13): G501–510.
Chung SA, Diamant NE. Small intestinal motility in fasted and postprandial states: effect of transient vagosympathetic blockade.Am J Physiol 1987; 252 (Gastrointest Liver Physiol 15): G301-G308.
Kinsman RJ, Read NW. Effect of naloxone on feedback regulation of small bowel transit by fat.Gastroenterology 1984; 87: 335–337.
Layer P, Ohe M, O, Leben J, Gröger G, Goebell H. Naloxone abolishes small intestinal motor but not pancreatic secretory responses to ileal carbohydrates in humans.Gastroenterology 1991; 100: A284.
Telford GL, Condon RE, Szurszewski JH. Opioid receptors and the initiation of migrating myoelectric complexes in dog.Am J Physiol 1989; 256 (Gastrointest Liver Physiol 19): G72–77.
Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ. Truncated GLP-1 (proglucagon 78–107-amide) from distal gut: role in regulation of gastric and pancreatic functions.Digestion 1990; 46: S1: 120.
Layer P, Gröger G, Holst JJ. Inhibition of pancreatic enzyme output in response to ileal perfusion with nutrients is associated with release of glucagon-like peptide 1 (GLP-1) in humans.Pancreas 1991; 6: 708.
Layer P, Holst JJ. GLP-1: a humoral mediator of the ileal brake in humans?Digestion 1993; 54: 385,386.
Gröger G, Goebell H, Holst JJ, Layer P. GLP-1 and PYY: mediators of the “ileal brake” on motility and gastric and pancreatic secretion in humans?Gut 1993; 34(2): 48.
Savage AP, Gornacz GE, Adrian TE, Ghatei MA, Goodlad RA, Wright NA, Bloom SR. Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response?Gut 1985; 26: 1353–1358.
Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR. Effect of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers.Gut 1987; 28: 166–170.
Levitt MD, Hirsh P, Fetzer CA, Sheahan M, Levine AS. H2-excretion after ingestion of complex carbohydrates.Gastroenterology 1987; 92: 383–389.